StockDuty ← Dashboard Oct 23, 2026 05:03 PM ET
SignalFDA/Bio

Doctors are calling Moderna and Merck's cancer vaccine data a major advancement despite Wall Street's reaction. Clinical validation is the signal here, and the tape can catch up once investors do a re

Doctors call Moderna, Merck cancer vaccine data a major advancement despite Wall Street reaction.

What happened: Six melanoma specialists said Moderna and Merck vaccine results represent a clinically meaningful result for melanoma patients who underwent surgery, despite Wall Street's reaction. Why it matters: The doctors' assessment supports the clinical significance of the data even as the market response differed.
MRNA
$223.37
-3.45%
MRK
$147.76
+0.55%
Six melanoma specialists said Moderna and Merck vaccine results represent a clinically meaningful result for melanoma patients who underwent surgery, despite Wall Street's reaction.
The doctors' assessment supports the clinical significance of the data even as the market response differed.
Sources